LeeAnn Chambers has been a Regulatory Affairs professional at Eli Lilly and Company for 22 years. She assists teams in developing global registration strategies for medical devices and drug / device combination products. She has guided the preparation of device content in US IND, NDA, and BLA submissions, EU Marketing Authorization Applications, US 510(k) submissions, CE Marking documentation, Japan device submissions and other global registration documents.